Search

everythinglearnresearchcommunity

for

Search:↓

Blocking YAP/TAZ could be a new way to treat skin cancer.

Epigenetic mechanisms control skin development by regulating gene expression.

Metabolic signals and cell shape influence how cells develop and change.

Understanding how certain proteins and genetic changes control skin stem cells is key to treating skin diseases.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Red light exposure can slow aging in mice by improving fat metabolism.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Some treatments can improve skin's defense against damage, but overuse may cause other skin problems.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

ceRNA networks offer potential treatments for skin aging and wound healing.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Stem cell differentiation involves gradual chromatin changes and dynamic gene activity.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Small molecule treatments improve the ability of human amniotic fluid stem cells to become different cell types.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

The protein EZH2 blocks microRNA-22, increasing STK40 protein, which helps hair follicle stem cells change and grow hair.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.